octnov2013
Pom Wonderful sued Coca-Cola in 2007, claiming the label on its pomegranate blueberry juice was misleading because the product is […]
In June 2013, the U.S. Supreme Court released its decision on “reverse payment” settlements between brand-name and generic drug makers. […]
A provision in the Manual of Patent Examining Procedure arguably broadens the duty to provide information that is material to […]
The Internet is undergoing a significant makeover with the rollout of hundreds of new generic Top Level Domains (gTLDs). They […]
Advanced technology companies today are essentially choosing to appropriate other companies’ technology rather than doing their own R&D, according to […]
As a result of the increase in global commerce and international corporate disputes, discovery of large volumes of data in […]
Developing a jury-friendly trial strategy in a patent case is critical to success. Reflecting on their medical device jury trial […]
Recent legislative and regulatory actions by states and municipalities, and new efforts by the EEOC, are restricting consideration of criminal […]
In a recent Delaware Chancery Court decision (Boilermakers Local 154 Retirement Fund, et al. v. Chevron Corporation and IClub Investment […]
There are three major mistakes made by compensation committees in hiring a new CEO: failure to set a compensation range […]
Get our free daily newsletter
Subscribe for the latest news and business legal developments.
Read this next
Top 100 Litigator Sues Blue Cross Over His Cancer Treatment
In 2018, Robert Salim, 67, realized he was seriously ill. After numerous […]
Financial Industry Suing to Foil New Regulations
New rules aimed at lenders, investment funds, and other financial entities would […]
GC Must Warn Boards Of AI Risks
There are companies investing hundreds of millions of dollars or more into […]